Early Computed Tomography Findings of Novel Coronavirus Disease 2019 (COVID-19) Pneumonia

dc.contributor.authorYilmaz, Pinar Diydem
dc.contributor.authorKadiyoran, Cengiz
dc.contributor.authorBakdik, Suleyman
dc.contributor.authorPoyraz, Necdet
dc.contributor.authorVatansev, Hulya
dc.date.accessioned2024-02-23T14:44:43Z
dc.date.available2024-02-23T14:44:43Z
dc.date.issued2020
dc.departmentNEÜen_US
dc.description.abstractBackground: Novel coronavirus disease (COVID-19) pneumonia is caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2), which is highly contagious and threatens human health. Chest computed tomography (CT) is an accurate imaging modality for diagnosis and follow-up. Objectives: To investigate early CT features of COVID-19 pneumonia. Methods: Retrospective study. Sixty-three patients with COVID-19 pneumonia (28 men, 35 women; age range, 21 - 85 years; mean, 59 years) confirmed by reverse transcription-polymerase chain reaction (RT-PCR) were enrolled in this retrospective study and CT findings were evaluated. Patients were classified into three groups for estimating COVID-19 pneumonia, according to CT features. Results: Nineteen (30%) patients classified as out of COVID-19 pneumonia had normal CT findings. Twenty-eight (44%) patients, classified as highly suggestive for COVID-19 pneumonia, had typical findings for COVID-19 pneumonia. In highly suggestive for COVID-19 pneumonia group most common CT features were peripheral (64%), multilobar (96%), patchy, and round (54%) ground-glass opacity (GGO) (57%). Air bronchogram (93%), crazy-paving patterns (79%), and vascular thickening (61%) were the mostcommon special findings. We only detected these rare findings such as halo sign, reverse halo sign, lymphadenopathy, pleural and pericardial effusion, pleural thickening, and fibrotic lines in patients with COVID-19 with chronic diseases. Conclusions: The early CT findings are peripheral, multilobar, patchy, and round ground glass opacities accompanied by vascular thickening, crazy-paving pattern, or air bronchogram sign. Rare findings are only seen in the presence of concomitant diseases.en_US
dc.identifier.doi10.5812/archcid.106868
dc.identifier.issn2345-2641
dc.identifier.issn2008-1081
dc.identifier.issue5en_US
dc.identifier.scopus2-s2.0-85097497911en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.urihttps://doi.org/10.5812/archcid.106868
dc.identifier.urihttps://hdl.handle.net/20.500.12452/17082
dc.identifier.volume15en_US
dc.identifier.wosWOS:000605002200010en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherBrieflanden_US
dc.relation.ispartofArchives Of Clinical Infectious Diseasesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPneumoniaen_US
dc.subjectComputed Tomography (Ct)en_US
dc.subjectCovid-19en_US
dc.subjectSars-Cov-2en_US
dc.subjectCoronavirus Diseaseen_US
dc.titleEarly Computed Tomography Findings of Novel Coronavirus Disease 2019 (COVID-19) Pneumoniaen_US
dc.typeArticleen_US

Dosyalar